ZA913071B - Treatment - Google Patents

Treatment

Info

Publication number
ZA913071B
ZA913071B ZA913071A ZA913071A ZA913071B ZA 913071 B ZA913071 B ZA 913071B ZA 913071 A ZA913071 A ZA 913071A ZA 913071 A ZA913071 A ZA 913071A ZA 913071 B ZA913071 B ZA 913071B
Authority
ZA
South Africa
Prior art keywords
treatment
arrythmias
atrial
cardiac
stroke
Prior art date
Application number
ZA913071A
Other languages
English (en)
Inventor
Alberto Julio Kaumann
Julio Kaumann Alberto
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of ZA913071B publication Critical patent/ZA913071B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Polarising Elements (AREA)
  • Mechanical Treatment Of Semiconductor (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
ZA913071A 1990-04-26 1991-04-24 Treatment ZA913071B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909009389A GB9009389D0 (en) 1990-04-26 1990-04-26 Treatment

Publications (1)

Publication Number Publication Date
ZA913071B true ZA913071B (en) 1992-11-25

Family

ID=10675031

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA913071A ZA913071B (en) 1990-04-26 1991-04-24 Treatment

Country Status (14)

Country Link
EP (1) EP0526540B1 (de)
JP (2) JPH05509293A (de)
AT (1) ATE181668T1 (de)
AU (1) AU653521B2 (de)
CA (1) CA2081344C (de)
DE (1) DE69131398T2 (de)
DK (1) DK0526540T3 (de)
ES (1) ES2134774T3 (de)
GB (1) GB9009389D0 (de)
GR (1) GR3031042T3 (de)
IE (1) IE911383A1 (de)
PT (1) PT97477B (de)
WO (1) WO1991016045A2 (de)
ZA (1) ZA913071B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020128172A1 (en) 1991-12-21 2002-09-12 Smithkline Beecham Plc Use of 5-HT4 modulators for the manufacture of a medicament for the treatment of the bladder diseases
US5852014A (en) * 1992-03-12 1998-12-22 Smithkline Beecham P.L.C. Condensed indole derivatives as 5HT4 -receptor antagonists
US5998409A (en) * 1992-03-12 1999-12-07 Smithkline Beecham Plc Condensed indole derivatives as 5HT4 -receptor antagonists
WO1994008965A1 (en) * 1992-10-16 1994-04-28 Smithkline Beecham Plc N-alkylpiperidinyl-4-methyl carboxylic esters/amides of condensed ring systems as 5-ht4 receptor antagonists
GB9301660D0 (en) * 1993-01-28 1993-03-17 Smithkline Beecham Plc Pharmaceuticals
US5684003A (en) * 1994-10-20 1997-11-04 Nisshin Flour Milling Co., Ltd. 5-HT4 receptor agonists
CA2418904A1 (en) * 2000-08-07 2002-02-14 Laboratoire Glaxosmithkline S.A.S. Use of 5ht4 receptor antagonists in the manufacture of a medicament for the prophylaxis or treatment of atrial fibrillation
GB0211230D0 (en) 2002-05-16 2002-06-26 Medinnova Sf Treatment of heart failure
US7737163B2 (en) 2004-06-15 2010-06-15 Pfizer Inc. Benzimidazolone carboxylic acid derivatives
CA2569654C (en) 2004-06-15 2010-12-21 Pfizer Inc. Benzimidazolone carboxylic acid derivatives
EP2153830A1 (de) * 2008-08-07 2010-02-17 Sanofi-Aventis Verwendung von Dronedaron zur Herstellung eines Medikaments zur Prävention von Schlaganfällen oder transienten ischämischen Anfällen
JP6574773B2 (ja) 2014-07-30 2019-09-11 株式会社アエタスファルマ １，４−ベンゾチアゼピン−１−オキシド誘導体の光学異性体、及びそれを用いた医薬組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3650772T2 (de) * 1985-04-27 2003-04-03 F. Hoffmann-La Roche Ag, Basel Derivate von Indazole-3-carboxamide und -3-carboxylsäure
US4731643A (en) * 1985-10-21 1988-03-15 International Business Machines Corporation Logic-circuit layout for large-scale integrated circuits

Also Published As

Publication number Publication date
EP0526540B1 (de) 1999-06-30
ES2134774T3 (es) 1999-10-16
CA2081344A1 (en) 1991-10-27
EP0526540A1 (de) 1993-02-10
DK0526540T3 (da) 1999-11-22
PT97477A (pt) 1992-01-31
CA2081344C (en) 2003-10-21
GR3031042T3 (en) 1999-12-31
JP2003267890A (ja) 2003-09-25
DE69131398T2 (de) 2000-03-02
AU653521B2 (en) 1994-10-06
DE69131398D1 (de) 1999-08-05
WO1991016045A3 (en) 1991-12-26
IE911383A1 (en) 1991-11-06
GB9009389D0 (en) 1990-06-20
PT97477B (pt) 1998-08-31
AU7768091A (en) 1991-11-11
JPH05509293A (ja) 1993-12-22
WO1991016045A2 (en) 1991-10-31
ATE181668T1 (de) 1999-07-15

Similar Documents

Publication Publication Date Title
PL299015A1 (en) Desquamative composition for use on human skin
GB2206788B (en) 5 ht-3 antagonist for the treatment or reduction of dependence
GB9009389D0 (en) Treatment
AU9064991A (en) Use of angiotensin ii receptor antagonists in the treatment of diabetic retinopathy
AU9084191A (en) Use of angiotensin ii receptor antagonists in the treatment of hemorragic stroke
EP0547178A4 (en) Novel cholecystokinin antagonists, their preparation and therapeutic use
AU4163793A (en) Angiotensin II receptor antagonists for the treatment and prophylaxis of coronary heart disease
DE3567211D1 (en) (pyrrol-1-yl)-phenyl-dihydropyridazinones, their preparation and use
EP0437026A3 (en) Use of tandospirone in the treatment of depression
AU9064191A (en) Use of angiotensin ii receptor antagonists in the treatment of atheroma
ZA849576B (en) 1,7-diphenyl-3-methyllaza-7-cyano-8-methylnonane for use in the treatment of diseases
EP0276573A3 (en) Use of 24,25-dihydroxycholecalciferol in the prophylaxis of bone senescence
CY2339B1 (en) Use of aminopurine antiviral agents for the treatment and prophylaxis of latent herpesvirus infections.
EP0427458A3 (en) Use of heptapeptides in the treatment or prophylaxis of muscle wasting
GR890100642A (en) Ultra mild skin cleansing composition
HK1012240A (en) Use of 5-ht4 receptor antagonists in the treatment of arrythmias and stroke
KR0139221B1 (en) Use of chlormethiazole in the prevention and/or treatment of neurodegeneration
EP0487985A3 (en) Process for the enhancement of riboflavin levels in spray-dried riboflavinfermentation extracts
GB9011406D0 (en) Hair-bearing skin area treatment
EP0565674A4 (de)
EP0407788A3 (en) Use of retinoids for the treatment and prophylaxis of immune related diseases
HUP9800272A3 (en) Use of penciclovir for the treatment of human herpes-virus-8
EP0596359A3 (de) Fluorierte 1,3-Benzo- und 1,3-Pyrido-dioxole, Verfahren zu deren Herstellung und deren Verwendung zur Herstellung von Pflanzenschutzmitteln.
IT1256925B (it) Impiego di frammenti o/e di derivati della timosina alfa 1.
ZA929143B (en) Agents for use in the prophylaxis and therapy of fungal infections.